Neurocrine Biosciences (NasdaqGS:NBIX) 2026 Conference Transcript

Neurocrine Biosciences (NasdaqGS:NBIX) 2026 Conference March 09, 2026 08:40 AM ET Speaker0Thanks for joining us. I'm Marc Goodman, one of the biopharma analysts at Leerink, and it's great to have Neurocrine here. We have Matt Abernathy, who's the CFO, and Todd Tushla, who's the IR guy. Thank you very much for joining us. Matt, I'll give you a chance just to make an opening comment, maybe not too long, but, you know, just kind of set the stage.Speaker1I'll try to run out the clock.Speaker0YeahSpeaker1if that ...